Kaliumiodid Serb (Potassium Iodide)

Potassium iodide provides a large amount of stable iodide that is taken up by the thyroid via the sodium‑iodide symporter. The excess iodide competitively blocks the organification of radioactive iodine, preventing its incorporation into thyroid hormones and thereby limiting radiation exposure to the gland.

The appropriate dose of Kaliumiodid Serb is determined by a qualified prescriber based on the specific clinical situation, such as the level of radiation risk or the degree of iodine deficiency. Patients should follow the dosing instructions provided by their healthcare professional.

Safety in pregnancy and breastfeeding has not been definitively established. Use is generally reserved for situations where the potential benefit outweighs any possible risk to the fetus or infant, and it should be prescribed and monitored by a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaliumiodid Serb delivers potassium iodide, the same active ingredient found in other stable‑iodine tablets used for thyroid blocking. Compared with alternative iodine sources such as potassium iodate, potassium iodide provides a more rapid and predictable increase in serum iodine levels, which is critical in emergency radiation scenarios.

The product should be stored at ambient temperature, below 25 °C, in its original packaging. It must be kept away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Kaliumiodid Serb is taken orally, usually as a tablet or solution, as directed by a healthcare professional. The medication should be swallowed with water unless the prescriber advises an alternative method of administration.

Serious risks include allergic reactions such as anaphylaxis, thyrotoxicosis (excess thyroid hormone activity), and severe hyperkalemia, especially in patients with renal impairment. Prompt medical attention is required if any signs of these conditions appear.

Individuals with known hypersensitivity to potassium iodide, untreated hyperthyroidism, or certain renal conditions should avoid using Kaliumiodid Serb unless a physician determines it is safe. Pregnant or breastfeeding women should only use it when the benefits clearly outweigh potential risks.